Intellia Therapeutics
Intellia Therapeutics, Inc. is a clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies. Leveraging gene editing technology, Intellia is developing novel, first-in-class medicines to meet important unmet needs and advance treatments for patients.